Skip to main content
Fig. 1 | Infectious Agents and Cancer

Fig. 1

From: Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)

Fig. 1

Vaccine immune response monitoring in previously infected and not previously infected cohorts of healthcare providers. Previously infected subjects = subjects previously infected to SARS-CoV-2. Not previously infected subjects = subjects not previously infected to SARS-CoV-2. Pre = anti - SARS-CoV-2 S titers (expressed in BAU/mL) before the first dose. Post I = anti - SARS-CoV-2 S titers (expressed in BAU/mL) 20 days after the first dose. Post II = anti - SARS-CoV-2 S titers (expressed in BAU/mL) 8 days after the second dose

Back to article page

Infectious Agents and Cancer

ISSN: 1750-9378

Contact us